Understanding how T cells respond to your drug candidate is key to bringing your treatment to market.
At Aquila, we offer a variety of T cell assays to help you study the nuances of T cell interaction with your drug candidate. Whether you are developing anti-inflammatory or anti-cancer therapies, our comprehensive panel of T cell assays will provide you with valuable efficacy data.
T cell assays can focus on individual T cell populations, allowing you to ask more targeted research questions, complementing data obtained from more complex, mixed cell populations (e.g. PBMCs). Our T cell polarisation assays are excellent tools to study your compounds’ effects on differentiation and function of T cells, and the pathogenesis of various inflammatory diseases e.g. autoimmune and allergic diseases. We have a suite of human Th1, Th2, Th17 and Treg cell assays with standard and custom readouts to suit your study requirements.
Whatever your research needs, we can tailor a package to suit you. Alone or in combination with other cells, we offer:
- T cell polarisation assay
- T cell stimulation assay
- T cell killing assay
- Treg suppression assay
- Antigen specific T cell assay
- Mixed lymphocyte reaction (MLR)
Please get in touch to learn more about our T cell related services.
